Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.41 |
| ▸ | CA1 | P00915 | 4/20 | 0.41 |
| ▸ | CA9 | Q16790 | 4/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.37 |
| ▸ | PREP | P48147 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.30 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.30 |
| ▸ | SRC | P12931 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3544897 | 0.93 | CYP1A1 (0.42) | CA12CA1CA9HSP90AA1HSP90AB1 | |
| SCHEMBL3542553 | 0.91 | CA12 (0.39) | CA12CA1CA9HSP90AA1HSP90AB1 | |
| SCHEMBL1417191 | 0.90 | CA12 (0.38) | CA12CA1CA9HSP90AA1HSP90AB1 | |
| SCHEMBL29520875 | 0.90 | CA12 (0.38) | CA12CA1CA9HSP90AA1HSP90AB1 | |
| SCHEMBL1616252 | 0.90 | CA12 (0.38) | CA12CA1CA9HSP90AA1HSP90AB1 | |
| SCHEMBL1952968 | 0.88 | CA12 (0.37) | CA12CA1CA9HSP90AA1HSP90AB1 | |
| SCHEMBL14534360 | 0.85 | AHR (0.40) | CA12CA1CA9PREPALDH1A1 | |
| SCHEMBL7193989 | 0.84 | CYP1A1 (0.46) | CA12CA1CA9HSP90AA1HSP90AB1 | |
| SCHEMBL17318153 | 0.83 | CA12 (0.47) | CA12CA1CA9HSP90AA1HSP90AB1 | |
| SCHEMBL1010834 | 0.82 | HSP90AA1 (0.50) | CA12CA1CA9HSP90AA1HSP90AB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7705188-B2 | Structural modification of resveratrol: sodium resverastatin phosphate | Arizona Board of Regents, a body corporate of the State of Arizona, Acting for and on Behalf of the Arizona State University (US) | 2010-04-27 | — | — | US | claimed |
| US-20200188878-A1 | MOLECULARLY IMPRINTED POLYMERS | MONASH UNIVERSITY (AU) | 2020-06-18 | — | — | US | disclosed |
| US-20200188878-A1 | MOLECULARLY IMPRINTED POLYMERS | MONASH UNIVERSITY (AU) | 2020-06-18 | — | — | US | disclosed |
| US-9738733-B2 | Polymers incorporating hydroxyl group-containing methylstyrene | BRIDGESTONE CORPORATION (JP) | 2017-08-22 | — | — | US | disclosed |
| US-9738733-B2 | Polymers incorporating hydroxyl group-containing methylstyrene | BRIDGESTONE CORPORATION (JP) | 2017-08-22 | — | — | US | disclosed |
| US-9738733-B2 | Polymers incorporating hydroxyl group-containing methylstyrene | BRIDGESTONE CORPORATION (JP) | 2017-08-22 | — | — | US | disclosed |
| US-20170002105-A1 | POLYMERS INCORPORATING HYDROXYL GROUP-CONTAINING METHYLSTYRENE | BRIDGESTONE CORPORATION (JP) | 2017-01-05 | — | — | US | disclosed |
| US-20170002105-A1 | POLYMERS INCORPORATING HYDROXYL GROUP-CONTAINING METHYLSTYRENE | BRIDGESTONE CORPORATION (JP) | 2017-01-05 | — | — | US | disclosed |
| US-20170002105-A1 | POLYMERS INCORPORATING HYDROXYL GROUP-CONTAINING METHYLSTYRENE | BRIDGESTONE CORPORATION (JP) | 2017-01-05 | — | — | US | disclosed |
| US-20160376263-A1 | BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF | SENOMYX INC (US) | 2016-12-29 | — | — | US | disclosed |
| US-7205425-B2 | Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof | CHISSO CORPORATION (JP) | 2007-04-17 | — | — | US | disclosed |
| US-20070060656-A1 | Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof | SHIBASAKI MASAKATSU | 2007-03-15 | — | — | US | disclosed |
| US-20050240062-A1 | Structural modification of resveratrol: Sodium resverastatin phosphate | NATIONAL INSTITUTES OF HEALTH | 2005-10-27 | — | — | US | disclosed |
| US-20050148801-A1 | Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof | JNC CORPORATION (JP) | 2005-07-07 | — | — | US | disclosed |
| EP-0947498-B1 | OPTICALLY ACTIVE NITRO ALCOHOL DERIVATIVES, OPTICALLY ACTIVE AMINO ALCOHOL DERIVATIVES, AND PROCESS FOR PREPARING THE SAME | CHISSO CORP (JP) | 2004-09-15 | — | — | EP | disclosed |
| WO-2003086414-A1 | STRUCTURAL MODIFICATION OF RESVERATROL: SODIUM RESVERASTATIN PHOSPHATE | ARIZONA BOARD OF REGENTS (US) | 2003-10-23 | — | — | WO | disclosed |
| US-6632955-B1 | Optically active 1-substituted phenyl-2-nitro alcohol derivatives which are useful pharmaceutical intermediates. Enantiomotphs active 1-substituted phenyl-2-nitro alcohol derivatives. From these nitro alcohol such as albutramin and | CHISSO CORPORATION (JP) | 2003-10-14 | — | — | US | disclosed |
| WO-2003024909-A1 | METHOD OF PREPARING SYMMETRICAL POLYHYDROXYSTILBENES | L'OREAL (FR) | 2003-03-27 | — | — | WO | disclosed |
| US-20020193447-A1 | Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof | JNC CORPORATION (JP) | 2002-12-19 | — | — | US | disclosed |
| EP-0947498-A1 | OPTICALLY ACTIVE NITRO ALCOHOL DERIVATIVES, OPTICALLY ACTIVE AMINO ALCOHOL DERIVATES, AND PROCESS FOR PREPARING THE SAME | CHISSO CORPORATION (JP) | 1999-10-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050148801-A1 | Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof | ADH1A, ALDH7A1, ADRB1 | CA12 4736/4885CA1 4707/4885CA9 4061/4885 |
| US-20160376263-A1 | BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF | TAS2R5, TAS1R1, TAS2R1 | CA12 4128/4885CA1 3404/4885CA9 2662/4885 |
| US-20050240062-A1 | Structural modification of resveratrol: Sodium resverastatin phosphate | PI4KB, HDAC4, PIK3CA | CA12 3079/4885CA1 2484/4885CA9 1412/4885 |
| US-20070060656-A1 | Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof | ADH1A, ALDH7A1, ADRB1 | CA12 4736/4885CA1 4707/4885CA9 4061/4885 |
| US-20200188878-A1 | MOLECULARLY IMPRINTED POLYMERS | IPMK, MPI, PIM3 | CA12 1571/4885CA1 2621/4885CA9 397/4885 |
| US-20020193447-A1 | Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof | ADH1A, ALDH7A1, SARM1 | CA12 4777/4885CA1 4704/4885CA9 4212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.